Photograph of Nicholas J. Diamond Download V-card

Nicholas J. Diamond

C&M International Director

ndiamond@crowell.com
Phone: +1 202.508.8954
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Nicholas J. Diamond is a director for C&M International, the global policy and regulatory affairs affiliate of Crowell & Moring LLP, in the Washington, D.C., office. His experience spans U.S. and global health policy, public health law, public international law, business and human rights, and ethics. His clients include both U.S. and international health sector stakeholders, with a particular emphasis on multinational biopharmaceutical companies.

Prior to joining C&M International, he worked as a consultant for a leading advisory firm in the U.S., where he counseled multinational biopharmaceutical companies, advocacy and trade organizations, and other health sector stakeholders. Earlier in his career, he led global market strategy for the health sector at a privately owned enterprise software company with a $1B+ valuation, as well as served in advisory roles to the U.S. government, including during implementation of landmark healthcare reform legislation.

Nick’s writing has been published in law reviews, peer-reviewed journals, and major media outlets. His writing has also been discussed or featured in major media outlets (e.g., The Washington Post, Slate, Forbes). He has given invited talks in various academic and industry fora, as well as frequently appeared on U.S. news programs (e.g., Bloomberg, MSNBC) as a commentator.

He also serves as an adjunct professor of law at the Georgetown University Law Center and as an associate scholar in the Center for Global Health at the University of Pennsylvania. He has previously taught at The George Washington University and Drexel University, as well as served as an adjunct fellow in the University of Pennsylvania’s Center for Public Health Initiatives.

He holds related affiliations as a member of the Executive Committee of the Framework Convention on Global Health Alliance (a Geneva-based NGO), an assistant editor of Wolters Kluwer’s Kluwer Arbitration Blog, and a contributor to Oxford University Press’ Investment Claims.

Since 2018, he has been a PhD candidate in public international law at Leiden Law School in The Hague. He has additional postgraduate training in law, bioethics, and global health.

Professional Activities and Memberships

  • Adjunct Professor of Law, Georgetown University Law Center
  • Associate Scholar, Center for Global Health at the University of Pennsylvania
  • Member, Executive Committee of the Framework Convention on Global Health Alliance
  • Assistant Editor, Wolters Kluwer’s Kluwer Arbitration Blog
  • Contributor, Oxford University Press’ Investment Claims

Education

  • Georgetown University, A.B. (2008)
  • Charleston School of Law, J.D. (2011)
  • Perelman School of Medicine at the University of Pennsylvania, MBE bioethics (2012)
  • Georgetown University Law Center, LL.M. global health law (2016) honors

Affiliations

View More

With FDA Approval Of First COVID-19 Vaccine, Let The Mandates Begin: US Military, Disney World, CVS Health And More USA Today (August 24, 2021)
Media Mentions
"Key Considerations in Utilizing Real World Evidence for Regulatory Decisions", DIA-CoRE Singapore Annual Meeting 2021 Panel Discussion (July 8, 2021). Session Chair: Nicholas J. Diamond.
Speech/Presentation
"Adapting Human Rights Due Diligence For Renewable Energy—Key Points," Bloomberg Law (July 2, 2021). Author: Nicholas J. Diamond.
Publication
"Procedural versus Substantive Reforms: Is the Work of UNCITRAL WGIII Worth the Wait?," Kluwer Arbitration Blog (June 27, 2021). Assistant Editor: Nicholas J. Diamond.
Publication
"Is Your Data Supply Chain Ethical? Don’t Restrict Due Diligence to Physical Operations.," Crowell & Moring’s Health Law Blog (June 15, 2021). Authors: Andrew Blasi and Nicholas J. Diamond.
Publication
"Vaccine Passport Success Rests On True Privacy, Equity, Security," Bloomberg Law (May 26, 2021). Authors: Jodi G. Daniel, Nicholas J. Diamond, and Roma Sharma.
Publication
"Three Takeaways From the May 21 Revised TRIPS Waiver Proposal," (May 25, 2021). Contacts: Robert Holleyman, Nicholas J. Diamond, Joshua Boswell
Client Alert / Newsletter
"Canada Releases Updated FIPA Model: A Step Forward for the ISDS System," International Dispute Resolution Alert (May 19, 2021). Contacts: Robert Holleyman, Ian A. Laird, Nicholas J. Diamond, Eduardo Mathison
Client Alert / Newsletter
Speed Bumps Ahead For IP Waiver But Will It Nudge Voluntary Licensing? Scrip Intelligence/Pink Sheet (May 12, 2021)
Media Mentions
"Five Key Questions Raised by the United States’ Decision to Support a Temporary TRIPS Waiver for COVID-19 Vaccines," (May 7, 2021). Contacts: Robert Holleyman, Terry Rea, Nicholas J. Diamond, Joshua Boswell, Christopher Pinto
Client Alert / Newsletter

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2021
Attorney advertising - prior results do not guarantee a similar outcome.